AI filing briefs · archive

8-K filings in November 2024, explained

513 material Form 8-K filings that 427 companies we cover made with the SEC in November 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

4 of 513 briefs match

newest first · times in ET
NABLN-able, Inc. Nov 20, 4:35 PM ET

N-able closes $100 million cash plus stock deal for Adlumin security platform

Neutral m&a Written later 1.013.027.01

N-able said on November 20, 2024 that it completed its acquisition of Adlumin, Inc., a cybersecurity company that provides extended detection and response and managed detection and response services. The company paid $100 million in cash and 1,570,762 shares of its common stock at closing, with additional deferred cash and up to $30 million in earn-out payments tied to performance targets. The filing also gave updated fourth-quarter and full-year 2024 revenue and adjusted EBITDA outlooks.

  • Closed November 20, 2024: about $100 million in cash, subject to customary adjustments, plus 1,570,762 shares of common stock
  • Deferred cash of $120 million, paid as $52.5 million and $67.5 million on the first and second anniversaries of closing
  • Up to $30 million in earn-out payments in 2025 and 2026 based on performance metrics
  • Full-year 2024 total revenue outlook of $463.0 million to $464.5 million, representing 10% year-over-year growth; fourth-quarter revenue outlook of $113.3 million to $114.8 million
Read the filing on SEC.gov ↗
ACADACADIA PHARMACEUTICALS INC Nov 20, 4:30 PM ET

Acadia Pharmaceuticals: COO Brendan Teehan Terminated Without Cause, Effective Immediately

Neutral leadership Written later 5.02

Acadia Pharmaceuticals said Executive Vice President, Chief Operating Officer and Head of Commercial Brendan Teehan was involuntarily terminated without Cause, effective immediately. Mr. Teehan will stay on as a non-executive employee through December 31, 2024 to help transfer his duties to a successor, and CEO Catherine Owen Adams will assume his responsibilities until one is appointed.

  • Brendan Teehan's executive role ended effective immediately, per an agreement dated November 18, 2024
  • Teehan remains a non-executive employee until December 31, 2024 to assist with the transition
  • CEO Catherine Owen Adams will assume his responsibilities until a successor is appointed
  • The filing does not name a successor or state the reason for the termination
Read the filing on SEC.gov ↗
WINGWingstop Inc. Nov 20, 8:22 AM ET

Wingstop agrees to sell $500 million of securitized notes due 2031 anticipated repayment

Neutral financing Written later 1.01

Wingstop and its subsidiaries signed a purchase agreement on November 19, 2024, under which a special purpose subsidiary will issue and sell $500 million of Series 2024-1 5.858% Fixed Rate Senior Secured Notes, Class A-2, in a private securitization. The closing is expected on December 3, 2024, subject to closing conditions, and the notes carry an anticipated repayment date in December 2031 with a legal final maturity in December 2054.

  • $500 million of Series 2024-1 5.858% Fixed Rate Senior Secured Notes, Class A-2, to be issued by Wingstop Funding LLC
  • Anticipated repayment date in December 2031; legal final maturity in December 2054
  • If not repaid or refinanced by the anticipated repayment date, additional interest accrues at the greater of 5.00% per annum and a Treasury-based formula plus 5.00% and 1.60%
  • Closing expected Tuesday, December 3, 2024; Morgan Stanley & Co. LLC and Barclays Capital Inc. are the initial purchasers
Read the filing on SEC.gov ↗
WSMWILLIAMS SONOMA INC Nov 20, 8:05 AM ET

Williams-Sonoma Q3 EPS rises 7.1% to $1.96 on lower sales; raises 2024 outlook

Mixed earnings Written later 2.02

Williams-Sonoma reported third-quarter 2024 results for the quarter ended October 27, 2024. Net revenues fell to $1.80 billion from $1.85 billion and comparable brand revenue declined 2.9%, but diluted EPS rose 7.1% to $1.96 on an operating margin of 17.8%, and the company raised its full-year 2024 outlook. The board also approved a new $1 billion stock repurchase authorization, and the raised margin guidance includes a $49 million out-of-period freight expense adjustment.

  • Net revenues were $1.80 billion versus $1.85 billion a year earlier; comparable brand revenue fell 2.9%.
  • Diluted EPS was $1.96 versus $1.83; operating margin was 17.8% versus 17.0%.
  • Full-year 2024 net revenue decline is now expected at -3.0% to -1.5%, and operating margin at 18.4% to 18.8%, including a $49 million out-of-period adjustment.
  • A new $1 billion stock repurchase authorization was approved in September 2024; total authorization is $1.3 billion, including $293 million remaining under the March 2024 program.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.